|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12N 15/11 | (2006.01) |
| C12N 15/63 | (2006.01) | ||
| C07K 19/00 | (2006.01) | ||
| C12N 15/10 | (2006.01) | ||
| C12N 15/90 | (2006.01) | ||
| A61K 38/46 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Number of the document | 3401400 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18152360.6 |
| Date of filing the European patent application | 2013-03-15 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation | 2019-06-10 |
| (30) | Number | Date | Country code |
| 201261652086 P | 2012-05-25 | US | |
| 201261716256 P | 2012-10-19 | US | |
| 201361757640 P | 2013-01-28 | US | |
| 201361765576 P | 2013-02-15 | US |
| (72) |
CHARPENTIER, Emmanuelle, DE
JINEK, Martin, US
DOUDNA CATE, James Harrison, US
LIM, Wendell, US
QI, Lei, US
CHYLINSKI, Krzysztof, AT
DOUDNA, Jennifer A., US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
University of Vienna, Universitätsring 1, 1010 Vienna, AT Charpentier, Emmanuelle, Department Of Regulation in Infection Biology Max Planck Institute for Infection Biology Charitéplatz 1, 10117 Berlin, DE |
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Būdai ir kompozicijos, skirtos RNR molekulės nukreipiamai tikslinės DNR modifikacijai ir RNR molekulės nukreipiamam transkripcijos moduliavimui |
| METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION |
| Payment date | Validity (years) | Amount | |
| 2024-02-20 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-11-11 |